Vancomycin Reduction Practices (VRP) in the NICU
Start Date
6/2/2025
Completion Date
9/1/2027
Summary
This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
External Facilitation
Conditions
Locations
Kaiser Permanente Modesto Medical Center
Modesto, California 95356
United States
Kaiser Permanente East Bay - Oakland Medical Center
Oakland, California 94611
United States
Kaiser Permanente Roseville Medical Center
Roseville, California 95661
United States
Kaiser Permanente San Francisco Medical Center
San Francisco, California 94115
United States
Kaiser Permanente San Leandro Medical Center
San Leandro, California 94577
United States
Kaiser Permanente Santa Clara Medical Center
Santa Clara, California 95051
United States
Kaiser Permanente Walnut Creek Medical Center
Walnut Creek, California 94596
United States
Medical Center of Princeton
Plainsboro, New Jersey 08536
United States
Virtua Voorhees
Voorhees Township, New Jersey 08043
United States
Lancaster General Hospital
Lancaster, Pennsylvania 17602
United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
Pennsylvania Hospital
Philadelphia, Pennsylvania 19107
United States
Chester County Hospital
West Chester, Pennsylvania 19380
United States